Latest: FDA Approves New Biosimilar for Oncology Treatment

Virtual Patients: How AI Simulation Is Revolutionizing Clinical Trials and Drug Development

0 Mins
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers. Drug development has long been marked by high costs, inefficiency, and human trial-and-error. Indeed, the cost of developing a single therapeutic exceeds $2.6 billion according to the Tufts Center for the Study of ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago